MDMA and serotonin syndrome: the differential

The post about stimulants in the emergency department covers agitation and the cardiovascular complications of stimulants; this text takes on another part of the problem: hyperthermia, clonus, hyponatremia and interactions with serotonergic medications. A twenty-two-year-old woman arrives at the emergency department at five in the morning, brought by friends from an electronic music party. She is agitated, sweaty, with tremor and involuntary movements in her legs, and her temperature is high. A friend says she took "bala" and that she has been on an antidepressant for a few months. Another recalls that she drank a lot of water to "not get dehydrated" and, in the last hour, began to become confused. The scene is fictional and was written for teaching. This text uses this picture as a scenario for clinical reasoning: how to recognize serotonergic toxicity, when to think of hyponatremia and how to tell it apart from other syndromes that also present with fever and neuromuscular changes.

NEXO is a daily medical diagnosis game: one clinical case a day, up to six progressive clues, and ICD-10 proximity feedback across five levels.

The text avoids being a treatment protocol. Doses, tests and workflows follow the protocols of each service and of toxicology, under supervision. Here the focus is the way of thinking: which physical examination findings separate the syndromes, what questions to ask about medications and why the same person can have two serious problems at the same time. If you play the case of the day in NEXO, you will recognize the movement: the right physical examination finding changes the weight of the hypotheses.

Key points

• Serotonergic toxicity is a clinical diagnosis, and the Hunter criteria rely mainly on clonus, hyperreflexia, tremor, agitation, sweating, hypertonia and a temperature above 38 °C in the presence of a serotonergic agent.
• Clonus is the clue that most helps to separate serotonergic toxicity from other hyperthermic syndromes.
• Severe cases usually involve a combination of serotonergic agents, such as antidepressants with MDMA or with other medications.
• Hyponatremia from MDMA results from the combination of water intake and antidiuretic hormone secretion, is more frequent in women and can cause confusion and seizures.
• Neuroleptic malignant syndrome, anticholinergic syndrome and malignant hyperthermia are part of the differential, and the neuromuscular examination and the exposure history help to separate them.

Why this differential is difficult

Someone who arrives at the emergency department with fever, agitation and neuromuscular changes after a party opens up a broad differential. It may be serotonergic toxicity, exertional and heat hyperthermia, hyponatremia, central nervous system infection, withdrawal, anticholinergic syndrome or, in people who use antipsychotics, neuroleptic malignant syndrome. Often, more than one of these problems appears at the same time.

The label "used ecstasy" helps to guide, but it also favors premature closure: the first plausible explanation ends the search. Pat Croskerry describes this and other shortcuts among the most frequent cognitive errors in diagnosis (Croskerry, 2003). In the opening case, closing on "MDMA intoxication" can hide two decisive questions: does the new confusion come from hyperthermia or from hyponatremia? Did the antidepressant in use turn a moderate intoxication into severe serotonergic toxicity?

Hall and Henry described acute MDMA toxicity as a set of conditions that includes hyperthermia with multiple organ failure, hyponatremia, serotonergic toxicity and other complications, and they stressed that those who work in emergency and intensive care need to know all of them (Hall and Henry, 2006).

Serotonergic toxicity: what the examination shows

Boyer and Shannon describe serotonin syndrome as a clinical spectrum that ranges from mild symptoms to life-threatening cases, with the triad of altered mental status, autonomic hyperactivity and neuromuscular abnormalities (Boyer and Shannon, 2005). The spectrum matters: the tremor and sweating of a mild case are different from the rigidity and hyperthermia of a severe case, and the reasoning needs to place the person within this spectrum.

A review of emergency cases reinforces that history and clinical examination are the basis of the diagnosis, that the picture can appear after overdose, an increase in therapeutic dose or an interaction between agents, and that treatment involves stopping the agent, supportive measures and, in some cases, specific medications (Morarasu and colleagues, 2022).

The Hunter criteria

Dunkley and colleagues developed the Hunter criteria from cases of intoxication by serotonergic agents seen by a toxicology service. In the presence of a serotonergic agent, the diagnosis is supported by one of the following combinations, and the criteria performed better than earlier criteria (Dunkley and colleagues, 2003):

• Spontaneous clonus.
• Inducible clonus plus agitation or sweating.
• Ocular clonus plus agitation or sweating.
• Tremor plus hyperreflexia.
• Hypertonia plus temperature above 38 °C and ocular or inducible clonus.

Clonus appears in almost all the combinations, and the findings tend to be more evident in the lower limbs. The neuromuscular examination, with testing of reflexes, ankle clonus and ocular clonus, is therefore the center of the assessment.

The neuromuscular examination step by step

In practice, many professionals look at the monitor and forget to examine the reflexes. A simple sequence helps make the Hunter criteria a habit:

1. Observe the person at rest, looking for tremor, myoclonus and involuntary eye movements.
2. Test the patellar and Achilles reflexes on both sides and compare with the upper limbs.
3. Test ankle clonus with rapid, sustained dorsiflexion of the foot.
4. Assess muscle tone, paying attention to rigidity in the lower limbs.
5. Repeat the examination after a few hours or after sedation, because the picture changes.

Recording each finding, including the negative ones descriptively, such as "symmetric and normal reflexes", helps whoever takes over the case on the next shift to notice the evolution.

Interactions: when the combination becomes the problem

Isbister and colleagues, in a practical approach to serotonergic toxicity, showed that severe cases tend to involve combinations of agents, especially monoamine oxidase inhibitors associated with other serotonergic drugs, and that treatment is based on stopping the agent and offering support (Isbister and colleagues, 2007). MDMA releases serotonin, and the sum with medications that increase serotonin availability raises the risk.

The question about medications is as important as the question about the drug used at the party. Many people use antidepressants, analgesics or migraine medications without thinking of them as serotonergic.

Medications that enter the question

• Antidepressants, such as selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclics and monoamine oxidase inhibitors.
• Opioid analgesics with a serotonergic effect, such as tramadol, fentanyl and methadone.
• Migraine medications and antiemetics that act on serotonin receptors.
• Antitussives such as dextromethorphan and antibiotics such as linezolid.
• Supplements and natural products, such as St John's wort.
• Other drugs used the same night, including substances sold as MDMA that contain other compounds.

The list is a support for reasoning, not a complete account. Checking with clinical pharmacy or the toxicology center helps when the exposure is uncertain. The combination of opioids with central nervous system depressants is discussed in the post about opioid overdose and the naloxone decision.

When the exposure is uncertain

A person does not always know what they took. Tablets and powders sold as MDMA may contain other substances, in variable doses, and friends often tell the story with gaps. That is why the reasoning starts from the clinical picture, not from the name of the drug reported. If the exam shows clonus and hyperreflexia, the hypothesis of serotonergic toxicity gains weight, whatever the substance. If it shows dry skin, urinary retention and normal reflexes, the anticholinergic hypothesis rises. Routine urine toxicology tests have limited reach and rarely change immediate management (Tenenbein, 2009), and the toxicology center helps interpret results and decide when further investigation is worthwhile.

MDMA-induced hyponatremia: the confusion that misleads

The second question in the opening scene is hyponatremia. Budisavljevic and colleagues described hyponatremia associated with MDMA as the result of a combination of excessive water intake and inappropriate secretion of antidiuretic hormone, with higher risk in young women, and warned that advice to drink large volumes of water may be inadequate (Budisavljevic and colleagues, 2003). A recent review reinforces that acute MDMA-induced hyponatremia can be life-threatening if untreated and that women have a higher incidence and a greater chance of severe effects (Garcia and colleagues, 2026).

The trap is clinical: confusion, headache, vomiting and seizures can be attributed to the drug or to hyperthermia, and sodium is left for later. In the opening scene, the clue of the large volume of water drunk and the progressive confusion call for sodium measurement right at the start.

Clues that suggest hyponatremia

1. Report of drinking large volumes of water or electrolyte-free beverages.
2. Confusion, headache, nausea and vomiting that worsen over hours.
3. Seizure, especially in a young woman after MDMA use.
4. Temperature only slightly raised or normal, with disproportionate mental alteration.
5. Little urine output despite water intake.

The advice to drink plenty of water to avoid dehydration circulates often at parties, and many people follow it with good intentions. That is why asking how much the person drank, and what, is as important as asking what they used. The answer usually comes from friends, and it is worth recording who provided the information, because it may change over the course of the night.

Sodium correction follows specific protocols, with attention to the rate, and the decision is made with the team and with the toxicology service. A person can have hyponatremia and serotonergic toxicity at the same time, and one does not rule out the other.

The differential of hyperthermic syndromes

Four syndromes are often confused when there is fever and neuromuscular alteration: serotonergic toxicity, neuroleptic malignant syndrome, anticholinergic syndrome and malignant hyperthermia. Boyer and Shannon organize this differential from the exposure history, the time of onset and the physical examination (Boyer and Shannon, 2005).

Syndrome	Typical exposure	Onset	Neuromuscular examination	Skin and pupils	Other clues
Serotonergic toxicity	Serotonergic agents, especially in combination	Rapid, within hours	Clonus, hyperreflexia, tremor, rigidity in the lower limbs	Sweating, mydriasis	Increased bowel sounds, diarrhea
Neuroleptic malignant syndrome	Dopamine antagonists, such as antipsychotics	Slower, over days	Generalized lead-pipe rigidity, reduced reflexes	Sweating	Progressive decline in consciousness, autonomic instability
Anticholinergic syndrome	Anticholinergic medications	Rapid	Reflexes and tone usually normal	Dry, hot skin, mydriasis	Urinary retention, reduced bowel sounds, delirium
Malignant hyperthermia	Inhaled anesthetics and succinylcholine	During or shortly after anesthesia	Intense rigidity	Hot skin	Increased exhaled carbon dioxide, surgical context

The table is a support for reasoning, not a fixed rule: the pictures overlap, and severe hyperthermia from any cause can produce rigidity and confusion.

Neuroleptic malignant syndrome

Strawn and colleagues describe neuroleptic malignant syndrome as a reaction to dopamine antagonists characterized by fever, rigidity, altered mental status and autonomic instability, with a slower onset than serotonergic toxicity (Strawn and colleagues, 2007). In people who use an antipsychotic and an antidepressant at the same time, the two syndromes can be confused, and the time of onset and the presence of clonus help to separate them.

Malignant hyperthermia

Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle, triggered by inhaled anesthetics and succinylcholine, and treated with dantrolene and discontinuation of the triggering agents (Rosenberg and colleagues, 2015). It rarely appears in the emergency department, but it enters the reasoning when the intoxicated person needs intubation and anesthesia, and the team needs to know how to distinguish the two.

Withdrawal and infection

Alcohol or benzodiazepine withdrawal also presents with agitation, tremor, sweating and fever. The post on CIWA-Ar shows how the scale measures symptoms, not their cause. Central nervous system infection enters the differential whenever there is fever and altered mental status, and a history of drug use does not rule out that possibility.

Other complications that count

Hall and Henry recall that MDMA hyperthermia can progress with multiple organ failure, and that other serious effects have been described over the years (Hall and Henry, 2006). In emergency department reasoning, this means actively looking for muscle injury, kidney injury, coagulation changes and liver injury in anyone arriving with significant hyperthermia, even when the temperature has already started to fall. Improvement of the fever is good news, but organ injury can appear later, and laboratory reassessment is part of follow-up.

The fictional example, again

Back to the young woman from the opening: she has agitation, sweating, tremor and involuntary movements in her legs, uses an antidepressant and took MDMA. Examination of the reflexes and testing for ankle clonus can confirm serotonergic toxicity by the Hunter criteria. At the same time, the intake of large volumes of water and progressive confusion call for sodium right from the start. Both hypotheses can be right. Reasoning that settles on only one of them risks treating the fever and missing severe hyponatremia, or correcting the sodium and underestimating the hyperthermia. Recording both hypotheses, with the tests that confirm or rule out each one, organizes the care and the communication with the team.

Principles of management and the reasoning behind them

Management follows each service's protocols and the guidance of the toxicology center. The principles, however, help to understand why each measure is taken. Boyer and Shannon and Isbister and colleagues describe stopping the serotonergic agents, supportive measures, sedation with benzodiazepines for agitation and, in moderate to severe cases, the use of serotonin antagonists such as cyproheptadine (Boyer and Shannon, 2005; Isbister and colleagues, 2007).

In severe hyperthermia, the reasoning changes: the high temperature comes from muscle activity, and Boyer and Shannon note that antipyretics play little role, because the mechanism differs from fever due to infection. Active cooling, sedation and, when necessary, muscle paralysis with intubation are the measures discussed in the literature for severe cases (Boyer and Shannon, 2005). Hall and Henry describe a similar set of measures for MDMA hyperthermia (Hall and Henry, 2006).

Observation and discharge

Mild cases, with slight tremor and sweating and no hyperthermia, usually improve within hours after the agents are stopped, according to the cited reviews. Moderate and severe cases call for longer observation and, often, intensive care. The decision on the length of observation considers the half-life of the drugs involved, the evolution of the neuromuscular examination, the sodium and the tests for organ injury. Before discharge, it is worth repeating the examination of reflexes and clonus and confirming that the person understood which medications need review with the prescriber.

Physical restraint and the risk of worsening

Severe agitation often leads to physical restraint. Restraint increases muscle activity against resistance and can worsen hyperthermia and muscle injury (Boyer and Shannon, 2005). For this reason, adequate sedation is usually preferred over prolonged restraint, and the restrained person needs frequent temperature monitoring.

Harm reduction after the emergency department

Discharge is an opportunity to talk about risks in a practical way: combining with antidepressants, drinking a moderate amount of water, taking breaks to cool the body, using with someone present, and testing substances where a service is available. The post on harm reduction beyond all or nothing develops this logic. Talking with the antidepressant prescriber also helps the person understand the interaction and decide with information.

The biases that get in the way of this differential

Premature closure. "Used ecstasy" ends the search, and hyponatremia or infection are left out.

Attributing everything to the drug. The confusion becomes a drug effect, and sodium is not measured.

Forgetting the medication list. The question about the party is asked, but the question about the antidepressant is left out.

Anchoring on fever. The high temperature leads to thinking about infection and antipyretics, and the reflex and clonus examination stays superficial.

Affective bias. Discomfort with the recreational use context reduces attention to the examination and the explanation.

A useful strategy against these biases is the safety question: "what else could it be, and what can I not miss?". In the case of fever with neuromuscular change, it forces you to remember hyponatremia, central nervous system infection and the other hyperthermic syndromes before closing the diagnosis. The post on differential diagnosis with clues shows how to train this habit.

If you want to review how useful shortcuts become a trap, the post on examples of heuristics in clinical reasoning organizes the main ones. The language used in the record also matters, and the post on stigma and language shows how the label changes management.

How NEXO helps train this reasoning

In NEXO, the case of the day is fictional, with a real clinical presentation and up to six progressive clues. You propose a diagnosis by searching for the code in ICD-10 and receive proximity feedback at five levels, which shows whether the guess stayed at the exact code, in the same category, in the same group, in the same chapter or in a different chapter. This format connects with the theme of this text: similar hyperthermic syndromes sit in different ICD-10 chapters, and the feedback shows when the neuromuscular clue was misread.

To use the case of the day as training, try three habits. Before each guess, write down which examination finding would separate the two main hypotheses. When an exposure seems to explain everything, ask what other problem could be present at the same time. After the result, note which clue you overvalued.

Three exercises with cases

Separate the four syndromes. For a fictional case with fever and rigidity, write what favors each of the four hyperthermic syndromes.

Review the medication list. In each case, note the medications mentioned and mark the ones with a serotonergic effect.

Look for the second problem. For a fictional case of intoxication, write a complication that could be present at the same time, such as hyponatremia.

The post on learning based on clinical cases shows why training with cases helps fix this type of decision.

The limits of use of the game are described on the NEXO Economy page. If you research the teaching of clinical reasoning, the page for Researchers explains how to get in touch. Professionals who write or review cases find information in Curator and in Creators, and institutions can learn about the proposal on the partnerships page.

Frequently asked questions

How do you confirm serotonin syndrome?

The diagnosis is clinical. The Hunter criteria, applied in the presence of a serotonergic agent, rely on clonus, hyperreflexia, tremor, agitation, sweating, hypertonia and temperature. Careful neuromuscular examination is the center of the assessment.

Which finding helps most to separate it from the other syndromes?

Clonus, whether spontaneous, inducible or ocular, is the most useful clue for serotonergic toxicity. Generalized rigidity with reduced reflexes and slow onset favors neuroleptic malignant syndrome.

Why is sodium part of the assessment of someone who used MDMA?

MDMA can cause hyponatremia through the combination of water intake and antidiuretic hormone secretion. Confusion, headache, vomiting and seizure can be signs of hyponatremia, and sodium clarifies the picture quickly.

Are people who take antidepressants at greater risk with MDMA?

Severe cases of serotonergic toxicity usually involve combinations of agents. Asking about antidepressants and other serotonergic medications is an essential part of the history.

Do antipyretics help with MDMA-induced hyperthermia?

Hyperthermia comes mainly from muscle activity, and the literature describes active cooling and sedation as central measures, according to the service protocol.

What should be discussed at discharge?

Risks of combining with medications, drinking water in moderate volume, breaks to cool the body, use with someone present and warning signs. Talking with the antidepressant prescriber also helps.

Final checklist

• I asked about the drug used and about all medications in use, including antidepressants and supplements.
• I examined reflexes, ankle clonus and ocular clonus.
• I measured sodium in anyone with confusion, headache, vomiting or seizure.
• I considered neuroleptic malignant syndrome, anticholinergic syndrome, malignant hyperthermia, withdrawal and infection.
• I discussed the case with the poison control center and followed the service protocol.
• I talked about harm reduction and interactions at discharge.

Want to practice the reasoning with progressive clues? Play today's case.

References

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-20. doi:10.1056/NEJMra041867. PMID 15784664.
2. Budisavljevic MN, Stewart L, Sahn SA, et al. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse. Am J Med Sci. 2003. PMID 12920440.
3. Croskerry P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med. 2003. PMID 12915363.
4. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003. PMID 12925718.
5. Garcia MR, Gomes NGM, Dias-da-Silva D. Rare but relevant: MDMA and hyponatraemia. Addiction. 2026. PMID 41360080.
6. Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006. PMID 16595612.
7. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007. PMID 17874986.
8. Morarasu BC, Coman AE, Bologa C, et al. Recognition and Management of Serotonin Toxidrome in the Emergency Department: Case Based Review. J Pers Med. 2022. PMID 36556289.
9. Rosenberg H, Pollock N, Schiemann A, et al. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015. PMID 26238698.
10. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007. PMID 17541044.
11. Tenenbein M. Do you really need that emergency drug screen? Clin Toxicol (Phila). 2009. PMID 19514875.